UnitedHealth Group (NYSE:UNH) Issues FY 2026 Earnings Guidance

UnitedHealth Group (NYSE:UNH) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 20.500- for the period, compared to the consensus earnings per share estimate of 19.860.

UnitedHealth Group Stock Up 0.0%

Shares of NYSE:UNH opened at $378.59 on Wednesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. The business has a 50 day simple moving average of $387.44 and a two-hundred day simple moving average of $382.57. UnitedHealth Group has a 1 year low of $255.96 and a 1 year high of $461.62. The firm has a market capitalization of $339.82 billion, a PE ratio of 24.36, a price-to-earnings-growth ratio of 1.42 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. The firm had revenue of $112.70 billion during the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%. UnitedHealth Group’s quarterly revenue was down .4% compared to the same quarter last year. During the same period last year, the company earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities analysts predict that UnitedHealth Group will post 19.85 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were issued a $2.32 dividend. This represents a $9.28 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Monday, September 14th. UnitedHealth Group’s dividend payout ratio is currently 59.72%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on UNH. Wells Fargo & Company raised their price target on UnitedHealth Group from $397.00 to $485.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. Zacks Research lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 14th. Bank of America restated a “buy” rating and set a $450.00 price objective on shares of UnitedHealth Group in a research note on Monday, July 20th. TD Cowen dropped their price objective on UnitedHealth Group from $430.00 to $402.00 and set a “hold” rating on the stock in a research report on Friday. Finally, Morgan Stanley increased their price target on UnitedHealth Group from $468.00 to $529.00 and gave the company an “overweight” rating in a research note on Friday, July 17th. Twenty research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average price target of $462.59.

Insider Activity

In related news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.19% of the stock is currently owned by insiders.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth reported adjusted earnings of $4.69 per share, well above the approximately $4.14 analyst consensus, while revenue of $112.7 billion also exceeded estimates. Operating earnings rose 52% to $6.6 billion, supported by tighter medical-cost controls and improved execution. UnitedHealth Group tops estimates, hikes profit outlook as insurer manages high medical costs
• Positive Sentiment: Management raised its 2026 adjusted EPS outlook to at least $20.50, above the roughly $19.86 consensus estimate. The company also indicated that current analyst expectations for 2027 may be conservative, reinforcing the view that its turnaround is progressing. UnitedHealth Says Wall Street May Be Underestimating Its 2027 Earnings Potential
• Positive Sentiment: The medical care ratio improved to 88.4%, while artificial-intelligence tools reportedly reduced clinical-review times and administrative friction. Management also expects Medicaid margins to bottom in 2026 and improve thereafter. UnitedHealth Group Earnings Call Highlights Growth and AI
• Neutral Sentiment: Despite the earnings beat, revenue was essentially flat year over year and Optum Health revenue slipped, suggesting that the recovery is being driven more by margins and cost discipline than by broad-based top-line expansion.
• Negative Sentiment: Investors remain concerned about UnitedHealth’s Medicare strategy, including the impact of exiting or reducing exposure to less-profitable Medicare business. Those concerns cloud the otherwise strong quarter and explain why the stock reversed its early advance. UnitedHealth Group Drops 5.4% as Medicare Exit Clouds Q3 Beat

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.